BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago Proposition de dividende de 0,69 euro par Sartorius Stedim Biotech Résultats Financiers Assemblée Générale Sartorius Stedim Biotech Aubagne Dividende 2025
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago Sartorius Stedim Biotech Proposes Steady Dividend for 2025 Biotech Industry Dividend Proposal Sartorius Stedim Biotech Annual Shareholders' Meeting 2025 Financial Results
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago Sartorius Stedim Biotech proposes a dividend of €0.69 Financial Results Sartorius Stedim Biotech General Assembly Aubagne 2025 Dividend
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago Sartorius Stedim Biotech propose un dividende stable pour 2025 Sartorius Stedim Biotech Proposition De Dividende Industrie Biotechnologique Résultats Financiers 2025 Assemblée Générale Annuelle Des Actionnaires
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago EXEL Industries Reports Share and Voting Rights Data as of December 31, 2025 Voting Rights Shares 2025 AMF Regulation EXEL Industries
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago EXEL Industries publie des données sur ses actions et ses droits de vote au 31 décembre 2025 Actions Règlement AMF Droit De Vote 2025 EXEL Industries
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago EXEL Industries : Répartition des Droits de Vote et Actions au 31 Décembre 2025 Droits De Vote Capital Social Actions AMF EXEL Industries
BRIEF published on 02/06/2026 at 11:50, 3 months 11 days ago EXEL Industries: Allocation of Voting Rights and Shares as of December 31, 2025 Share Capital Voting Rights Actions AMF EXEL Industries
BRIEF published on 02/06/2026 at 11:48, 3 months 11 days ago Supervisory Board of Sartorius AG Proposes Dividend for 2025 Annual General Meeting Dividend Proposal Sartorius AG Biopharmaceutical Sector 2025 Financials
BRIEF published on 02/06/2026 at 11:48, 3 months 11 days ago Le conseil de surveillance de Sartorius AG propose un dividende pour 2025 Sartorius AG Assemblée Générale Annuelle Proposition De Dividende Secteur Biopharmaceutique Données Financières 2025
Published on 05/16/2026 at 01:15, 1 day 22 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 23 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 7 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 3 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 5 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 8 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 8 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 13 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 14 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 5 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
